Initial digest — GHSR1a receipt

what this node claims

Initial digest — GHSR1a

AlphaFold v6 prediction landed for **GHSR1a** (Growth hormone secretagogue receptor 1a (ghrelin receptor)). UniProt accession: `Q92847`. Lane: `metabolic`. Mean per-residue pLDDT: **81.6**. Endogenous ghrelin receptor...

Open source surface Research pack

vertical proof spine

evidence / risk instrument

76%

usable with debt

low debt pressure 20%

82%structurestrong

pLDDT 81.6

55%evidencethin

grade C

60%gatesusable

3/5 gates

100%riskstrong

0 hard flags

92%exportstrong

surface linked

100%lineagestrong

complete spine

proof completeness

100% complete spine

01 target
02 fold
03 alphafold metric
04 candidate
05 finding
06 export

Metrics and receipt inputs

confidence: 0.6
evidence refs: 1

AlphaFold metrics visual

Confident backbone model

81.6

366 residues / min 27.77 / max 98.75 / source alphafold db

Very high 50.8% 186 residues / >=90

Confident 27.3% 100 residues / 70-89

Low 11.5% 42 residues / 50-69

Very low 10.4% 38 residues / <50

usable fold context with explicit model-confidence limits

Near-complete coverage / observed 366 of 366 residues.

residues 1-36 / mean 35.02
residues 341-366 / mean 56.57
residues 284-294 / mean 65.33
residues 246-251 / mean 60.33

proof debt register

Visible limits, not hidden cleanup.

20%

Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.

high low evidence grade attach graded finding with source-linked evidence

low computational-only status add independent evidence, challenge result, or witness review before strengthening

What would stop this from becoming stronger.

debt severity export claim strength next proof needed

low evidence grade high blocks weakens attach graded finding with source-linked evidence

computational-only status low visible watch add independent evidence, challenge result, or witness review before strengthening